In consideration of the market penetration.
I'm in the same boat, having held since listing, or near enough to. I work in Pathology labs and thought it was a no brainer, still do, only wasn't anticipating the brainlessness of the status quo.
Agree it's just not progressing the Earnings bit of the P/E to justify hanging in there, doubling revenues each period or year at one stage........ I just don't think it's a very sexy disease.
The low false positivity driving economic viability might appear to a drug company as someone eating their lunch. Powerful incumbents profiting from the status quo will at the very least indifferent to such arguments. As will the ticket clippers, sorry doctors, who's follow up consults equate to repeat customers.
No brainer indeed, oh how the nieve (thats me) come to learn.
- Forums
- ASX - By Stock
- big sell orders
In consideration of the market penetration.I'm in the same boat,...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
Add CST (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.7¢ |
Change
-0.001(1.28%) |
Mkt cap ! $18.62M |
Open | High | Low | Value | Volume |
7.8¢ | 7.8¢ | 7.7¢ | $4.771K | 61.93K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5062 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 2906 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5062 | 0.077 |
2 | 300000 | 0.076 |
1 | 7000 | 0.075 |
2 | 80000 | 0.070 |
1 | 8000 | 0.068 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 2906 | 1 |
0.082 | 54125 | 1 |
0.084 | 29850 | 1 |
0.086 | 15337 | 1 |
0.125 | 35001 | 1 |
Last trade - 15.49pm 09/10/2024 (20 minute delay) ? |
Featured News
CST (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online